Variant report
Variant | nsv1027038 |
---|---|
Chromosome Location | chr5:35503887-35556247 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:8)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:35553551..35555369-chr5:35555940..35558510,2 | K562 | blood: | |
2 | chr5:35547826..35549736-chr5:35553724..35555878,2 | MCF-7 | breast: | |
3 | chr5:35540756..35542538-chr5:35544282..35546249,2 | MCF-7 | breast: | |
4 | chr5:35547826..35549736-chr5:35553724..35555878,2 | MCF-7 | breast: | |
5 | chr5:35540756..35542538-chr5:35544282..35546249,2 | MCF-7 | breast: | |
6 | chr5:35539988..35542729-chr5:35548091..35550770,2 | K562 | blood: | |
7 | chr5:35553551..35555369-chr5:35555940..35558510,2 | K562 | blood: | |
8 | chr5:35539988..35542729-chr5:35548091..35550770,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs78359512 | chr5:35513461-35513462 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs183236163 | chr5:35513467-35513468 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs60775377 | chr5:35513508-35513509 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs57874690 | chr5:35513522-35513523 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs187529228 | chr5:35513523-35513524 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs114967254 | chr5:35513530-35513531 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs569589748 | chr5:35513560-35513561 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs533853682 | chr5:35513586-35513587 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs528028615 | chr5:35513587-35513588 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs376921905 | chr5:35513591-35513592 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs558467935 | chr5:35513592-35513593 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs566746603 | chr5:35513594-35513595 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs549045216 | chr5:35513617-35513618 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs577997211 | chr5:35513735-35513736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs533933056 | chr5:35513749-35513750 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs150537928 | chr5:35513759-35513760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs184221573 | chr5:35513860-35513861 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs115374964 | chr5:35513863-35513864 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs187844864 | chr5:35513879-35513880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs555905626 | chr5:35513889-35513890 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs77100635 | chr5:35513911-35513912 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs111531563 | chr5:35513961-35513962 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs544928582 | chr5:35513993-35513994 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs565015446 | chr5:35513998-35513999 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs527329168 | chr5:35514002-35514003 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs540624917 | chr5:35514049-35514050 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs138620005 | chr5:35514067-35514068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs141525582 | chr5:35514069-35514070 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs549621198 | chr5:35514114-35514115 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs374675919 | chr5:35514116-35514117 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs569501689 | chr5:35514163-35514164 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs373808341 | chr5:35514188-35514189 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs531927282 | chr5:35514236-35514237 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs552144341 | chr5:35514279-35514280 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs193208430 | chr5:35514327-35514328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs534200428 | chr5:35514348-35514349 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs146190771 | chr5:35514361-35514362 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs567763954 | chr5:35514432-35514433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs557805817 | chr5:35514433-35514434 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs184391758 | chr5:35514451-35514452 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs189427336 | chr5:35514454-35514455 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs140172933 | chr5:35514457-35514458 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs558819742 | chr5:35514483-35514484 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs572207788 | chr5:35514492-35514493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs541039625 | chr5:35514526-35514527 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs560697158 | chr5:35514537-35514538 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs529692787 | chr5:35514559-35514560 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs149855821 | chr5:35514591-35514592 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs78336151 | chr5:35514592-35514593 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs542241789 | chr5:35518020-35518021 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myofibroblastic sarcoma | 19369631 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Breast cancer | 19553991 | CNVD |
Lung cancer | 19553991 | CNVD |
Melanoma | 19553991 | CNVD |
Ovarian cancer | 19553991 | CNVD |
Prostate cancer | 19553991 | CNVD |
Non-small cell lung cancer | 17156491 | CNVD |
Breast cancer | 17133270 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Breast cancer | 17393978 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Lung cancer | 19153074 | CNVD |
Breast cancer | 21364760 | CNVD |
Cornelia de Lange syndrome | 21085971 | CNVD |
Autism | 21701786 | CNVD |
Cervical cancer | 16585170 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:35513400-35514600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
2 | chr5:35518000-35519000 | Enhancers | Primary monocytes fromperipheralblood | blood |
3 | chr5:35518000-35519000 | Enhancers | Monocytes-CD14+_RO01746 | blood |
4 | chr5:35519800-35520000 | Enhancers | Gastric | stomach |
5 | chr5:35520000-35520600 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr5:35538800-35539000 | Enhancers | Liver | Liver |
7 | chr5:35539000-35540000 | Weak transcription | Liver | Liver |
8 | chr5:35540200-35540400 | Enhancers | Liver | Liver |
9 | chr5:35541600-35553400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr5:35542800-35543800 | Enhancers | Monocytes-CD14+_RO01746 | blood |
11 | chr5:35543000-35543800 | Enhancers | Primary monocytes fromperipheralblood | blood |
12 | chr5:35543800-35545200 | Weak transcription | Primary monocytes fromperipheralblood | blood |
13 | chr5:35543800-35545200 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
14 | chr5:35545200-35545400 | Enhancers | Primary monocytes fromperipheralblood | blood |
15 | chr5:35545200-35545600 | Active TSS | IMR90 fetal lung fibroblasts Cell Line | lung |
16 | chr5:35545200-35545800 | Enhancers | Dnd41 | blood |
17 | chr5:35545200-35545800 | Enhancers | Monocytes-CD14+_RO01746 | blood |
18 | chr5:35545200-35545800 | Active TSS | NHLF | lung |